Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification is a research paper published in Journal of Thoracic Oncology (2023). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P01-CA129243-12
National Cancer Institute
Grant: 1R01CA251591-01A1
National Cancer Institute
Grant: P30-CA008748
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P01 CA129243
NCI NIH HHS
Grant: R01 CA251591
NCI NIH HHS
Grant: R01 CA252658
Canadian Institutes of Health Research
Grant: unidentified
unidentified
FWCI
3.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals